Abrysvo is Outpatient Formulary, Restrictedfor maternal immunization in pregnant individuals 32-36 weeks.
Abrysvo is Inpatient Formulary, Restricted to PREGNANT individuals, weeks 32-36, who are admitted through delivery, with delivery anticipated to be ≥ 14 days out from vaccine administration.
See Arexvy and mRESVIA for formulary status of other RSV vaccines.
Add Formweb to your mobile device
Abrysvo is Outpatient Formulary, Restricted for maternal immunization in pregnant individuals 32-36 weeks.
Abrysvo is Inpatient Formulary, Restricted to PREGNANT individuals, weeks 32-36, who are admitted through delivery, with delivery anticipated to be ≥ 14 days out from vaccine administration.
See Arexvy and mRESVIA for formulary status of other RSV vaccines.